When eCOA and IRT operate together on a single platform, those decisions can happen in real time, with built-in, automated gates and triggers that guide sites through screening and randomization with greater clarity and confidence.
This case study explores how a biopharmaceutical sponsor used the Suvoda Platform with unified eCOA and IRT to streamline screening and randomization in a global dermatology study.
Download the case study to see how unified technology helped: